UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS. James Hawkins 01/03/2026 James Hawkins 01/03/2026 Efficacy and Safety of the Neuroplastogen TSND-201 for the Treatment of PTSD A Randomized Clinical Trial Read More James Hawkins 01/03/2026 James Hawkins 01/03/2026 Neurorestorative Properties of Ibogaine: Linking Multi-Receptor Affinities to Remyelination and Metabolic Restoration Read More James Hawkins 01/03/2026 James Hawkins 01/03/2026 The psychoactive effects of repeated ketamine infusions and their mechanistic role in the treatment of alcohol use disorder: Secondary analysis of a randomised controlled trial Read More James Hawkins 01/03/2026 James Hawkins 01/03/2026 Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depression Read More James Hawkins 22/02/2026 James Hawkins 22/02/2026 Single-dose DMT reverses anhedonia and cognitive deficits via restoration of neurogenesis in a stress-induced depression model Read More James Hawkins 22/02/2026 James Hawkins 22/02/2026 Lifetime MDMA use and associations with meaning in life in the context of childhood trauma Read More James Hawkins 22/02/2026 James Hawkins 22/02/2026 Trip sitting or just sitting? Acute psychedelic experiences vary little between session facilitators in healthy trials but substantially in clinical ones. Read More James Hawkins 22/02/2026 James Hawkins 22/02/2026 Compass Pathways Successfully Achieves Primary Endpoint in Second Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression Read More James Hawkins 14/02/2026 James Hawkins 14/02/2026 The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials Read More James Hawkins 14/02/2026 James Hawkins 14/02/2026 Accelerated recovery using magnesium ibogaine: characterizing the subjective experience of its rapid healing from neuropsychiatric disorders Read More James Hawkins 14/02/2026 James Hawkins 14/02/2026 Self-medication with psychedelics: a scoping review and narrative synthesis of review-level evidence Read More James Hawkins 14/02/2026 James Hawkins 14/02/2026 Ayahuasca Enhances Functional Connectivity in the Third Visual Pathway and Mirror Neuron Networks: a Crossover, Multiple-Dose fMRI Study Read More James Hawkins 07/02/2026 James Hawkins 07/02/2026 Psilocybin exerts differential effects on social behavior and inflammation in mice in contexts of activity-based anorexia Read More James Hawkins 07/02/2026 James Hawkins 07/02/2026 Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysis Read More James Hawkins 07/02/2026 James Hawkins 07/02/2026 Learning from boundlessness: epistemic shifts towards a holistic worldview following psychedelic experiences Read More James Hawkins 07/02/2026 James Hawkins 07/02/2026 Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study Read More James Hawkins 02/02/2026 James Hawkins 02/02/2026 Predicting and exploring ayahuasca effects: Perception, mind-wandering, and EEG oscillations Read More James Hawkins 02/02/2026 James Hawkins 02/02/2026 The Relationship Between Participant Pretreatment Clinical Presentation and the Quality of Psilocybin Experience: A Retrospective Analysis Read More James Hawkins 01/02/2026 James Hawkins 01/02/2026 Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysis Read More James Hawkins 01/02/2026 James Hawkins 01/02/2026 5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) for alcohol use disorder: An open-label, phase 2, proof-of-concept, clinical trial Read More Older Posts
James Hawkins 01/03/2026 James Hawkins 01/03/2026 Efficacy and Safety of the Neuroplastogen TSND-201 for the Treatment of PTSD A Randomized Clinical Trial Read More
James Hawkins 01/03/2026 James Hawkins 01/03/2026 Neurorestorative Properties of Ibogaine: Linking Multi-Receptor Affinities to Remyelination and Metabolic Restoration Read More
James Hawkins 01/03/2026 James Hawkins 01/03/2026 The psychoactive effects of repeated ketamine infusions and their mechanistic role in the treatment of alcohol use disorder: Secondary analysis of a randomised controlled trial Read More
James Hawkins 01/03/2026 James Hawkins 01/03/2026 Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depression Read More
James Hawkins 22/02/2026 James Hawkins 22/02/2026 Single-dose DMT reverses anhedonia and cognitive deficits via restoration of neurogenesis in a stress-induced depression model Read More
James Hawkins 22/02/2026 James Hawkins 22/02/2026 Lifetime MDMA use and associations with meaning in life in the context of childhood trauma Read More
James Hawkins 22/02/2026 James Hawkins 22/02/2026 Trip sitting or just sitting? Acute psychedelic experiences vary little between session facilitators in healthy trials but substantially in clinical ones. Read More
James Hawkins 22/02/2026 James Hawkins 22/02/2026 Compass Pathways Successfully Achieves Primary Endpoint in Second Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression Read More
James Hawkins 14/02/2026 James Hawkins 14/02/2026 The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials Read More
James Hawkins 14/02/2026 James Hawkins 14/02/2026 Accelerated recovery using magnesium ibogaine: characterizing the subjective experience of its rapid healing from neuropsychiatric disorders Read More
James Hawkins 14/02/2026 James Hawkins 14/02/2026 Self-medication with psychedelics: a scoping review and narrative synthesis of review-level evidence Read More
James Hawkins 14/02/2026 James Hawkins 14/02/2026 Ayahuasca Enhances Functional Connectivity in the Third Visual Pathway and Mirror Neuron Networks: a Crossover, Multiple-Dose fMRI Study Read More
James Hawkins 07/02/2026 James Hawkins 07/02/2026 Psilocybin exerts differential effects on social behavior and inflammation in mice in contexts of activity-based anorexia Read More
James Hawkins 07/02/2026 James Hawkins 07/02/2026 Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysis Read More
James Hawkins 07/02/2026 James Hawkins 07/02/2026 Learning from boundlessness: epistemic shifts towards a holistic worldview following psychedelic experiences Read More
James Hawkins 07/02/2026 James Hawkins 07/02/2026 Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study Read More
James Hawkins 02/02/2026 James Hawkins 02/02/2026 Predicting and exploring ayahuasca effects: Perception, mind-wandering, and EEG oscillations Read More
James Hawkins 02/02/2026 James Hawkins 02/02/2026 The Relationship Between Participant Pretreatment Clinical Presentation and the Quality of Psilocybin Experience: A Retrospective Analysis Read More
James Hawkins 01/02/2026 James Hawkins 01/02/2026 Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysis Read More
James Hawkins 01/02/2026 James Hawkins 01/02/2026 5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) for alcohol use disorder: An open-label, phase 2, proof-of-concept, clinical trial Read More
